This panel focuses on detecting inherited genetic mutations that increase the risk of colorectal cancers, including Lynch syndrome and familial adenomatous polyposis (FAP). It evaluates 44 genes and is recommended for individuals with a personal or family history of colorectal, endometrial, or gastrointestinal cancers. By identifying pathogenic mutations, this test allows for early intervention strategies such as enhanced screening, lifestyle changes, and prophylactic treatments. It is a valuable resource for those seeking to understand their inherited risk and adopt preventive measures that could significantly improve outcomes.
Our Tests
NIPT (Non-Invasive Prenatal Test) Gender
NIPT Gender is the simplest version of the NonInvasive Prenatal Test (NIPT), designed for parents who primarily want to know their baby’s sex early in pregnancy.
NIPT (Non-Invasive Prenatal Test) Basic
NIPT Basic is the entrylevel NonInvasive Prenatal Test designed to screen for the most common chromosomal conditions in pregnancy.
NIPT (Non-Invasive Prenatal Test) Standard
NIPT Standard is a more comprehensive version of the NonInvasive Prenatal Test, designed for parents who want deeper insights into their baby’s chromosomal health.
NIPT (Non-Invasive Prenatal Test) Plus
NIPT Plus is an advanced version of the NonInvasive Prenatal Test (NIPT) designed to give expecting parents the most comprehensive view of their baby’s chromosomal health.
Comprehensive Hereditary Cancer Test (~300 genes)
Covers breast, ovarian, colorectal, prostate, pancreatic, gastric, melanoma, endocrine, and more.
Hereditary Breast and Ovarian Cancer Test (50 genes)
BRCA1/2 and related genes for breast and ovarian cancer risk.
Hereditary Prostate Cancer Test (23 genes)
Genes linked to inherited prostate cancer risk.
Hereditary Pancreatic Cancer Test (32 genes)
Genes associated with inherited pancreatic cancer risk.
Hereditary Colorectal Cancer Test (44 genes)
Genes for Lynch syndrome and other colorectal risks.